Search for: "Mylan Pharmaceuticals"
Results 161 - 180
of 739
Sort by Relevance
|
Sort by Date
27 Dec 2018, 7:54 am
The recalled products were manufactured by some of the world’s largest pharmaceutical companies, including Teva Pharmaceuticals, Mylan Pharmaceuticals, Kimberly-Clark, Abbott and Bayer. [read post]
24 Dec 2018, 6:08 am
The CBS Evening News reported, Mylan Pharmaceuticals expanded its recall of blood pressure medications to include Valsartan-containing products. [read post]
19 Dec 2018, 11:46 am
Earlier this month, Mylan Pharmaceuticals announced a recall of three blood pressure medications that were found to contain small amounts of a substance believed to cause cancer. [read post]
11 Dec 2018, 4:55 am
Here’s an event for you | Public procurement of pharmaceuticals and the patent system, the first date of a stormy relationship? [read post]
27 Nov 2018, 9:05 am
Impurities found in Mylan’s valsartan API is known as N-nitroso-diethylamine (NDEA), which has been classified as a probable human carcinogen. [read post]
15 Nov 2018, 10:21 am
The case involved secondary usage of a known and patented pharmaceutical compound—applying an already patented pharmaceutical compound to a new use. [read post]
14 Nov 2018, 3:25 am
Mylan and Actavis brought separate claims for revocation of the patent in 2014, on the ground that the claims were insufficiently disclosed. [read post]
6 Nov 2018, 4:18 am
Anders ValentinAs previously reported, in 2017 the Danish Maritime and Commercial Court declined to grant an application filed by Gilead to grant an injunction against Accord offering the pharmaceutical a combination product consisting of Emtricitabine and Tenofovir Disoproxil (TD), holding that the granted SPC was invalid (Ground-breaking decision on Gilead’s Tenofovir SPC in Denmark). [read post]
24 Oct 2018, 1:47 pm
Mylan Pharmaceuticals Inc., App. [read post]
12 Oct 2018, 1:24 pm
Mylan Pharmaceuticals Inc., Nos.17-1594, 17-1595, 17-1596 (Fed. [read post]
3 Oct 2018, 8:51 am
Mylan Pharmaceuticals). [read post]
12 Sep 2018, 9:46 am
This case was originally filed in March 2016 by Galderma against Amneal Pharmaceuticals under the HatchWaxman Act, 35 U.S.C. [read post]
10 Sep 2018, 10:17 am
.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
10 Sep 2018, 6:25 am
Here: En Banc Petition States Amicus Brief University of Minnesota Brief University of New Mexico Amicus Brief Prior posts here. [read post]
22 Aug 2018, 7:21 am
" Noven Pharmaceuticals, Inc. v. [read post]
21 Aug 2018, 9:58 pm
Mylan Pharmaceuticals Inc., affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
8 Aug 2018, 11:15 pm
Mylan Pharmaceuticals, Inc. [read post]
27 Jul 2018, 6:00 am
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
27 Jul 2018, 6:00 am
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
25 Jul 2018, 12:47 pm
Mylan Pharmaceuticals Inc. et al., the U.S. [read post]
